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Abstract
Migration is crucial for the function of dendritic cells (DCs), which act as outposts of the
immune system. Upon detection of pathogens, skin- and mucosa-resident DCs migrate to
secondary lymphoid organs where they activate T cells. DC motility relies critically on the
actin cytoskeleton, which is regulated by the actin-related protein 2/3 (ARP2/3) complex, a
nucleator of branched actin networks. Consequently, loss of ARP2/3 stimulators and
upstream Rho family GTPases dramatically impairs DC migration. However, nothing is
known yet about the relevance of ARP2/3 inhibitors for DCmigration. We previously demon-
strated that the AP-1-associated adaptor protein Gadkin inhibits ARP2/3 by sequestering it
on intracellular vesicles. Consistent with a role of Gadkin in DC physiology, we here report
Gadkin expression in bone marrow-derived DCs and show that its protein level and post-
translational modification are regulated upon LPS-induced DCmaturation. DCs derived
from Gadkin-deficient mice were normal with regards to differentiation and maturation, but
displayed increased actin polymerization. While the actin-dependent processes of macropi-
nocytosis and cell spreading were not affected, loss of Gadkin significantly impaired DC
migration in vitro, however, in vivo DCmigration was unperturbed suggesting the presence
of compensatory mechanisms.
Introduction
Cell migration is essential for the functioning of the immune system. Dendritic cells (DCs) are
a pivotal example for this fact due to their far apart lying places of action [1]. DC migration
from the periphery to draining lymph nodes is crucial for the induction of an adaptive immune
response against invading pathogens [2]. Immature DCs reside as sentinels for the detection of
pathogens in exposed tissues such as skin and mucosal surfaces, where they continuously sam-
ple foreign antigens [1]. Pathogen encounter triggers DC maturation e.g. via Toll-like recep-
tors, which includes an increase in the surface levels of the chemokine receptor CCR7 [3] as
well as the upregulation of co-stimulatory molecules to efficiently prime T cells. Guided by
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gradients of the CCR7 ligands CCL21 and CCL19, DCs emigrate from the tissue interstitium
and enter afferent lymphatic vessels to reach the draining lymph nodes [4]. Noteworthy,
CCL21 seems to be more important for DC homing as mice lacking CCL19 show neither aber-
rant DC maturation nor migration deficits [5]. In lymph nodes, DCs present the processed
antigen to naive T cells thereby selecting T cells carrying a cognate antigen receptor from the
enormous T cell repertoire and inducing adaptive immunity. Hence, DC function is not possi-
ble without coordinated and directed long-distance cell migration.
Functional DCs are also of special interest as promising tools for new anti-tumor therapies
[6]. Ex vivo generated DCs have been tested as vaccines in anti-cancer therapies and were able
to expand T cells specific for cancer antigens [7], however, only about 1% of injected DCs
migrated successfully to the draining lymph node [7] rendering the approach very inefficient.
Thus, unraveling the mechanisms underlying DC migration is not only of cell biological inter-
est, but also crucial for the optimization of DC-based therapeutic approaches.
While DC migration on two-dimensional (2D) surfaces requires adhesive forces, migration
of DCs in three-dimensional (3D) environments was shown to occur independent of integrins.
Instead the amoeboid-like migratory mode observed in 3D mainly relies on rapid cycles of
actin polymerization [8]. Efficient actin polymerization requires actin nucleators such as the
ARP2/3 complex, which catalyzes the formation of branched actin networks [9]. In order to be
catalytically active, ARP2/3 requires stimulation by nucleation promoting factors (NPFs) like
WASP. NPFs in turn are controlled by small GTPases of the Rho family including Cdc42 and
Rac, which release them from auto-inhibition [9]. While the consequences of ARP2/3 loss on
DC migration have not been reported, depletion of Rac1/2 [10], Cdc42 [11], WASP [12] or the
actin regulator Eps8 [13] severely impaired DC migration to lymph nodes. Dysfunction of
WASP is in fact associated with the primary immunodeficiency disorder Wiskott-Aldrich syn-
drome, which comprises an increased susceptibility to severe and life-threatening infections
[14], illustrating the importance of regulated actin dynamics for the proper functioning of the
immune system. However, ARP2/3 is not only controlled by activators, but also by a number
of inhibitory factors, yet the physiological relevance of ARP2/3 inhibitors on DC migration has
not been addressed. We have previously identified the AP-1-associated adaptor protein Gadkin
[15] as a direct interactor of ARP2/3 [16]. In B16F1 melanoma cells, Gadkin sequestered
ARP2/3 on endosomal vesicles in the absence of pro-migratory signaling thereby inhibiting
ARP2/3-dependent processes such as cell spreading and cell migration [16].
Consistent with a role of Gadkin in DC physiology, we here report alterations in Gadkin
protein levels and its posttranscriptional modification upon LPS-induced DC maturation. Cap-
italizing on a Gadkin-deficient mouse model previously established in our lab [16], we gener-
ated Gadkin-deficient bone marrow-derived DCs to examine the role of Gadkin in DC
migration in vitro and in vivo. Loss of Gadkin led to an increase in polymerized actin levels and
impaired DC motility in both two-dimensional (2D) and three-dimensional (3D) in vitro envi-
ronments. However, in vivomigration of Gadkin-deficient DCs appeared to be unaffected,
likely due to compensatory mechanisms and the known robustness of DC migration [8].
Results
Gadkin is expressed in immune cells
The AP-1-associated adaptor protein Gadkin is present in a wide range of tissues [16]. The high
expression level of Gadkin in the spleen (Fig 1A), an important secondary lymphoid organ,
prompted us to determine the expression of Gadkin in the thymus as a primary lymphoid organ
and in several important subsets of immune cells. Interestingly, Gadkin was not only detected in
thymus, but also in primary bone marrow-derived DCs (BMDCs), and in B and T lymphocytes
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isolated from spleen (Fig 1B). Parallel analysis of Gadkin-deficient tissues verified the specificity
of the bands obtained by immunoblotting with human [17] resp. newly generated mouse Gad-
kin-specific antibodies (for details about antibodies see Table 1). These results demonstrate the
expression of the ARP2/3 inhibitor Gadkin in highly motile immune cells, including BMDCs,
and thus lay the basis for investigating the role of Gadkin in DCmigration.
Gadkin is not required for DC differentiation and maturation
Immature BMDCs were differentiated in vitro by culturing bone marrow suspensions of WT
and Gadkin-/- mice in the presence of granulocyte macrophage colony-stimulating factor
(GM-CSF). Successful differentiation was confirmed by flow cytometrical analysis of CD11c
surface levels, a marker protein of mouse DCs. WT and Gadkin-/- BMDCs expressed CD11c to
a similar degree (Fig 2A and 2B) indicating that BMDC differentiation is Gadkin-independent.
After eight days of culture, BMDC maturation was induced by treatment with bacterial lipo-
polysaccharide (LPS), a Toll-like receptor ligand, which triggers upregulation of a number of
molecules that are critical for the function of mature DCs, among them major histocompatibil-
ity complex II (MHCII), the chemokine receptor CCR7 and co-stimulatory molecules such as
Fig 1. Gadkin is expressed in lymphoid organs and in immune cells. A. Lysates of WT and Gadkin-/- (labeled as KO) tissues were analyzed by
immunoblotting using Gadkin- and AP-1-specific antibodies. B. Lysates of WT and Gadkin-/- thymus, of DCs derived fromWT and Gadkin-/- bone marrow, as
well as of B lymphocytes (i.e. B220-positive B cells) and T lymphocytes (i.e. CD3-positive T cells) isolated from spleen were analyzed by immunoblotting
using Gadkin-specific antibodies. Detection of the constitutively expressed molecular chaperone heat shock cognate protein 70 (Hsc70) was used as loading
control. B, B-lymphocytes; T, T-lymphocytes.
doi:10.1371/journal.pone.0143883.g001
Table 1. Antibodies.
Antigen Species Clone name or catalog # Supplier IF WB FACS Comments
Actin mouse ac-15 Sigma-Aldrich 1:1000
AP-1 mouse 610386 BD Biosciences 1:100 specific for γ-adaptin
B220/CD45R rat RA3-6B2 BD Pharmingen 1:100 biotin-labeled
CD3e hamster 145-2C11 eBioscience 1:100 FITC-labeled
CD8a rat 53–6.7 eBioscience 1:100 APC-labeled
CD11c hamster N418 Invitrogen 1:400 FITC-labeled
CD40 rat 1C10 eBioscience 1:200 APC-labeled
CD80 hamster 16-10A1 eBioscience 1:100 PE-labeled
CD86 rat GL1 eBioscience 1:100 APC-labeled
CD197/CCR7 rat 4B12 eBioscience 1:10 APC-labeled
Gadkin rabbit #13 home-made 1:500 anti-human Gadkin; purified [17]
Gadkin rabbit 854-F2 home-made 1:50 1:5000 anti-mouse Gadkin; purified
Hsc70 mouse MA3006 Affinity Bioreagents 1:5000
p34 rabbit 07–227 Millipore 1:400
IF, immunofluorescence; WB, western blotting.
doi:10.1371/journal.pone.0143883.t001
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Fig 2. Loss of Gadkin does not affect in vitro DC differentiation andmaturation. Bone marrow-derived
WT and Gadkin-/- DCs both display hallmark features of DC differentiation and maturation. A. Untreated,
immature WT and Gadkin-/- DCs were analyzed by flow cytometry with CD11c-specific fluorescently labeled
antibodies. The diagrams depict the number of cells counted at different fluorescence intensities. Cells with a
fluorescence intensity of at least 101 were defined as CD11c-positive amounting to 84–85% of all cells. B.
Quantification of mean fluorescence intensity for CD11c in immature and 24 h LPS-matured WT and
Gadkin-/- BMDCs based on flow cytometry (N = 3 independent experiments). C,E,G,I. Immature WT and
Gadkin-/- BMDCs were left untreated (red line) or were matured by incubation with LPS for 24 h (blue line) and
subsequently analyzed by flow cytometry with the indicated fluorescently labeled antibodies. The diagrams
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CD40, CD80 and CD86. To assess DC maturation we measured surface levels of CD40, CD80,
CD86 and CCR7, which are common markers to distinguish between immature and mature
DCs in mice [18]. As expected, immature BMDCs expressed low levels of these markers, while
LPS-treated BMDCs displayed strongly and significantly elevated levels of all markers (Fig 2C–
2J). There was no difference in the surface levels of the tested markers between WT and Gad-
kin-/- BMDCs indicating that in vitro DCmaturation is not affected by loss of Gadkin.
To analyze whether this holds true for in vivoDC differentiation we quantified the percentage
of different DC subsets in erythrocyte-depleted cell suspensions derived fromWT and Gadkin-/-
spleens by flow cytometry. First we compared the overall abundance of DCs as characterized by
expressing CD11c betweenWT and Gadkin-/- spleens. There was neither a difference in the per-
centage of CD11c-positive cells relative to the entire splenocyte population (Fig 3) nor a change
in the absolute number of spleen-resident CD11c-positive cells (absolute number in KO as % of
WT: 108.5 ± 10.7 (N = 2)) betweenWT and Gadkin-/- mice. We then went on to evaluate differ-
ent DC subsets since DCs form a very heterogeneous group of cells. The main populations
depict the number of cells counted at different fluorescence intensities for both conditions illustrating the
increase in surface expression of the tested markers after LPS treatment. D,F,H,J. Quantification of mean
fluorescence intensity for the indicated marker proteins in immature and LPS-matured (24 h) treatedWT and
Gadkin-/- BMDCs based on flow cytometry (N = 3 independent experiments for D and J, N = 4 independent
experiments for F and H, significance was tested with one-way ANOVA followed by Tukey´s test to compare
all groups, * = p<0.05, ** = p<0.01, *** = p<0.001).
doi:10.1371/journal.pone.0143883.g002
Fig 3. Loss of Gadkin does not affect generation of splenic DC subsets in vivo.WT and Gadkin-/-
spleens were processed into erythrocyte-depleted cell suspensions, and the percentage of different DC
subsets relative to total splenocytes was quantified by flow cytometry using CD11c, CD8 and B220 as
markers for the different DC populations (N = 3 independent experiments). Pos, positive; neg, negative;
pDCs, plasmacytoid DCs.
doi:10.1371/journal.pone.0143883.g003
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present in murine spleen are conventional DCs, which are subdivided in CD8-positive DCs, the
most efficient subset for cross-presentation, and CD8-negative DCs, the more potent CD4+ T
cell activators, as well as B220-positive plasmacytoid DCs, which are especially efficient in secret-
ing anti-viral cytokines [19]. However, when quantifying these different DC subsets, we also did
not detect any changes betweenWT and Gadkin-/- spleens (Fig 3). Thus DCs arise in vivo with
the same efficiency inWT and Gadkin-/- mice arguing against a differentiation defect.
LPS-induced BMDCmaturation regulates Gadkin protein levels and
posttranslational modification
The maturation of DCs in response to pathogens involves a plethora of changes that prime
DCs for migration to lymph nodes and subsequent T cell activation. If Gadkin is an important
factor for these processes, it might be regulated upon LPS treatment. In fact, when we analyzed
Gadkin protein levels 24 h post LPS treatment by immunofluorescence and immunoblotting,
we detected a>2-fold significant increase in its expression level, while Gadkin´s subcellular
localization to the perinuclear recycling compartment remained unaltered (Fig 4A, 4B and
4D). In addition to the maturation-induced long-term increase in Gadkin levels, which occurs
on the time scale of hours, we observed the appearance of a very closely spaced additional Gad-
kin-specific band of lower electrophoretic mobility in immunoblots. This second band
appeared about 30 min after LPS application and had disappeared again 1.5 h later, indicative
of a transient posttranslational modification of Gadkin (Fig 4B and 4C). While this is the first
indication of Gadkin being regulated by posttranslational modification, the exact nature of this
modification remains to be determined. The coordinated regulation of Gadkin in the context
of DC maturation strongly argues for a role of Gadkin in DC function.
Loss of Gadkin affects the actin cytoskeleton of BMDCs
AP-1 and ARP2/3 are two of the most important interactors of Gadkin expressed by DCs.
However loss of Gadkin did not change the intracellular distribution of AP-1 (Fig 5A) or
ARP2/3 (Fig 5B). Likewise the amount of ARP2/3 quantified via its subunit p34/ARPC2 did
not differ in Gadkin-/- BMDCs (Fig 5C). Still, based on the hypothesis that Gadkin acts also in
DCs as a negative regulator of ARP2/3, the amount of polymerized actin might be increased in
Fig 4. Gadkin is regulated in an LPS-dependent manner. A-D. LPS treatment of BMDCs increases Gadkin levels and induces its transient
posttranscriptional modification. A. Immature WT BMDCs were either left untreated or incubated for 24 h with LPS. Subsequently, cells were allowed to
spread on fibronectin-coated cover slips for 15 min to achieve a more uniform morphology prior to analysis. Cells were processed for immunofluorescence
and labeled with Gadkin-specific antibodies. Nuclei were stained with DAPI. Insets show 2x enlarged perinuclear area. Scale bar: 10 μm. B,C. Lysates from
WT BMDCs treated with LPS for the indicated times were analyzed by immunoblotting using Gadkin- and Hsc70-specific antibodies. The closely spaced
upper band is indicated by red arrows. D. Quantification of immunoblot images like the one depicted in B. Gadkin levels were normalized to Hsc70 levels
derived from the same blot. (N = 3 independent experiments, unpaired two-tailed t-test; * = p<0.05; a.u., arbitrary units).
doi:10.1371/journal.pone.0143883.g004
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Fig 5. Loss of Gadkin leads to an increase of F-actin. A. AP-1 localization is not altered in the absence of
Gadkin. WT and Gadkin-/- BMDCs were matured for 24 h with LPS. Subsequently, BMDCs were allowed to
spread on fibronectin-coated cover slips for 240 min prior to fixation and staining with Gadkin- and AP-
1-specific antibodies. Scale bar: 10 μm. B. ARP2/3 and F-actin localization appears unaltered in the absence
of Gadkin. BMDCs treated as in A. were incubated with ARP2/3-specific antibodies against the subunit p34/
ARPC2 and with fluorescently labeled phalloidin to stain F-actin. Scale bar: 10 μm. C. The level of ARP2/3 is
not changed in Gadkin-/- BMDCs. Immunofluorescence-based quantification of the mean fluorescence
intensity of the ARP2/3 subunit p34/ARPC2 (N = 5 independent experiments, unpaired t-test, ns = non
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Gadkin-deficient BMDCs. As Gadkin is known to sequester ARP2/3 especially in non-stimu-
lated cells [16], we quantified the level of polymerized actin in serum-starved LPS-matured
BMDCs by staining them with fluorescently-labeled phalloidin prior to flow cytometrical anal-
ysis. Indeed, mature Gadkin-/- BMDCs displayed a significantly elevated level of F-actin, which
is in line with our hypothesis (Fig 5D).
Loss of Gadkin does not affect macropinocytosis of BMDCs
To address whether the observed difference in F-actin affects actin-dependent processes in
BMDCs we started by investigating macropinocytosis of FITC-dextran. Macropinocytosis
denotes the bulk uptake of fluid-phase solutes via the actin-dependent formation of large vesi-
cles [20]. DCs are known to constitutively macropinocytose large quantities of exogenous sol-
ute as part of their sentinel function [20]. However, when comparing the amount of
macropinocytosed FITC-dextran after different time intervals, we did not detect any difference
between WT and Gadkin-/- BMDCs (Fig 6).
Loss of Gadkin does not affect cell spreading of BMDCs
The ARP2/3 complex is not only implicated in macropinocytosis, but known to be required for
efficient cell spreading [21]. Previously, we have shown that loss of Gadkin promotes B16F1
melanoma cell spreading [16]. To assess whether loss of Gadkin also affects spreading of
significant). D. Gadkin-/- BMDCs contain more F-actin. Flow cytometry-based quantification of phalloidin-
stained suspension cells that had been starved for 1 h (N = 7 independent experiments, unpaired t-test, ** =
p<0.01).
doi:10.1371/journal.pone.0143883.g005
Fig 6. Macropinocytosis is unaltered in Gadkin-/- BMDCs. Immature WT and Gadkin-/- BMDCs were incubated with FITC-dextran for the indicated time
intervals. FITC-Dextran uptake was quantified by flow cytometry (N = 2 independent experiments).
doi:10.1371/journal.pone.0143883.g006
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mature BMDCs, WT and Gadkin-/- BMDCs were plated onto fibronectin 24 h post LPS treat-
ment and allowed to spread for different time intervals. However, the spreading behavior of
Gadkin-/- BMDCs was indistinguishable from that of WT cells (Fig 7).
Loss of Gadkin impairs CCR7-driven DCmigration in 2D
The ARP2/3 complex is crucial for cellular motility, and depletion of ARP2/3 regulators in
DCs impaired DC migration in 2D environments [22]. To determine whether loss of Gadkin
likewise affects DC migration in 2D, we seeded LPS-matured WT and Gadkin-/- BMDCs into
the upper reservoirs of Transwells and let them migrate for 3 h towards the chemokine CCL19
or CCL21 present in the lower reservoirs. Subsequently, the number of cells having migrated to
the lower reservoir was assessed by flow cytometry. For both chemokines tested Gadkin-/-
BMDCs migrated significantly less efficiently towards the chemokine than WT DCs (Fig 8A
and 8B). This migration impairment may either indicate a defective response to the chemotac-
tic cue or a mechanistic problem with cell migration itself, possibly due to alterations in actin
dynamics. The latter possibility was supported by the fact that Gadkin-/- BMDCs displayed
impaired random migration in the absence of chemokines (WT: 1.15 ± 0.07, KO: 0.85 ± 0.07,
p<0.05 in paired one-tailed t-test, N = 6 independent experiments). Differences in DC migra-
tion might be caused by alterations of DC velocity or in their directional persistence. As the
Transwell assay is an endpoint assay, which does not allow to dissect these different migration
parameters, we turned to live cell imaging of DCs in 2D chemotaxis chambers, where DCs
migrate along a chemokine gradient. Analysis of DC tracks revealed a moderate, but significant
decrease in the velocity of LPS-matured Gadkin-/- BMDCs consistent with a significantly
reduced accumulated and Euclidian distance covered by the Gadkin-/- BMDCs in the course of
the experiment, while the directionality of migration was not altered (Fig 8C–8H).
Loss of Gadkin affects DC migration in 3D environments
DCmigration in 2D and 3D environments follows different modes. 2D migration of DCs
requires adhesive forces to generate traction, while their migration in 3D environments can
Fig 7. Gadkin is dispensable for spreading of mature BMDCs. A. Gadkin-/- BMDCs display no alterations
in cell spreading. WT and Gadkin-/- BMDCs were matured for 24 h with LPS. Subsequently, cells were
allowed to spread on fibronectin-coated cover slips for 15 to 240 min. Cells were processed for
immunofluorescence and incubated with phalloidin to stain F-actin and thus visualize cell shape. Cell size
was quantified at the indicated times post-plating (N = 2 independent experiments for 15 min time point and
N = 4 for 30 and 240 min time points).
doi:10.1371/journal.pone.0143883.g007
Role of Gadkin in Dendritic Cell Migration
PLOS ONE | DOI:10.1371/journal.pone.0143883 December 1, 2015 9 / 20
Fig 8. Loss of Gadkin impairs BMDC chemotaxis in 2D. A,B. LPS-maturedWT and Gadkin-/- BMDCs
were seeded into Transwell inserts and allowed to migrate for 3 h towards 250 ng/ml CCL19 (A) resp. 250 ng/
ml CCL21 (B). Migration towards the chemokine was analyzed by flow cytometry. Values were subtracted for
unspecific migration towards chemokine-free medium to determine the specific migration towards chemokine
and then normalized to the average value of each experiment (N = 6 independent experiments, unpaired two-
tailed t-test, * = p<0.05). C-H. LPS-matured WT and Gadkin-/- BMDCs were seeded into a 2D chemotaxis
chamber. BMDCs were allowed to migrate for 4 h towards 650 ng/ml CCL19, and their migratory behavior
was evaluated based on bright-field images obtained at 2 min intervals. C,D. Migration tracks of 21 WT (C)
Role of Gadkin in Dendritic Cell Migration
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solely be driven by the force of actin-network expansion [8, 22]. In line with these mechanistic
differences, ablation of genes that regulate actin dynamics like Cdc42 caused especially pro-
nounced defects in 3D DC migration [11]. To determine whether loss of Gadkin also has a
greater impact on 3D migration, we embedded BMDCs into collagen type I gels mimicking col-
lagen-rich connective tissue and therefore constituting an in vivo like environment [22]. LPS-
matured WT and Gadkin-/- BMDCs seeded into a chemokine-free collagen gel moved with
comparable speed (WT: 2.03±0.21 μm/min, N = 3; KO: 2.11±0.15 μm/min, N = 4) and similar
directionality (WT: 0.60±0.02, N = 3; KO: 0.61±0.01, N = 4). The migratory behavior of Gad-
kin-/- BMDCs was likewise unaltered in the presence of a CCL19 gradient (Fig 9A–9D). Inter-
estingly, less efficient 3D migration of Gadkin-/- BMDCs was only observed in the presence of
CCL21 (Fig 9A–9D), the chemokine towards which migration of Gadkin-/- BMDCs had also
been more severely impaired in the Transwell assay and which is in vivo the more important
chemokine for DC homing [5]. Gadkin-/- BMDCs migrated significantly slower than WT
BMDCs along the CCL21 gradient, while their directionality was again unaffected. In sum-
mary, loss of Gadkin causes moderate but significant defects in 3D migration in the presence of
CCL21, which are in the same range as defects observed during 2D in vitro chemotaxis.
Loss of Gadkin can be compensated in vivo resulting in unaltered DC
homing to draining lymph nodes
Collagen gels represent a simplified approximation of the complex fibrillar environment of der-
mal interstitial tissues and cannot recapitulate all migration steps, which DCs have to achieve
on their way from the dermal interstitium via afferent lymphatics to the draining lymph node.
Therefore, we turned to in vivomigration experiments to elucidate whether the in vitromigra-
tion impairment of Gadkin-/- BMDCs translates into a decreased arrival at draining lymph
nodes in vivo. The disturbed chemotaxis of Gadkin-/- BMDCs towards CCL21 might be espe-
cially detrimental in vivo, as endogenous gradients of CCL21 within mouse skin were shown to
guide DCs towards lymphatic vessels [4].
We assessed in vivomigration by two approaches. First we analyzed migration of endoge-
neous skin-resident DCs in response to skin irritation. To this end, we cutaniously applied the
skin irritant dibutylphthalate together with the dye FITC to the abdomen of WT and Gadkin-/-
mice. Dibutylphthalate induces DC maturation and thereby triggers their migration to drain-
ing lymph nodes, while FITC is efficiently taken up by skin-resident DCs resulting in their fluo-
rescent labeling. Arrival of FITC-positive DCs in the draining lymph node was assessed by flow
cytometry and revealed no significant difference between WT and Gadkin-/- DC migration (Fig
10A and 10B). In a second approach we labeled in vitro differentiated and matured WT and
Gadkin-/- BMDCs with different dyes and injected them in a 1:1 mixture into the footpads of
C57BL/6 mice. Similar numbers of transferred WT and Gadkin-/- BMDCs arrived in the drain-
ing popliteal lymph node, as determined by flow cytometry (Fig 10C and 10D). In conclusion,
loss of Gadkin does not detectably impair the efficiency of DC migration from dermal tissue to
draining lymph nodes in vivo, suggesting that loss of Gadkin in DCs can be compensated, pre-
sumably by changing the mode of migration.
and 23 Gadkin-/- BMDCs (D) centered on the same starting point. Center of mass depicted as blue cross (WT:
x = 10.57 μm, y = 326.38 μm, KO: x = 4.26 μm, y = 213.79 μm). Velocity (E) was quantified as well as the
accumulated (F) and Euclidian distance (G) covered by the BMDCs. Directionality (H) was calculated as
Euclidian distance divided by accumulated distance (N = 4 independent experiments, at least 20 cells per
experiment were tracked, paired two-tailed t-test for distances, paired one-tailed t-test for velocity, * =
p<0.05).
doi:10.1371/journal.pone.0143883.g008
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Discussion
Immune cell migration throughout the organism is essential for successful immune surveil-
lance and the induction of innate and adaptive immunity. This particularly holds true for DCs,
which have to navigate throughout the body in order to sample foreign antigens in peripheral
tissues and display them to T cells in secondary lymphoid organs to mount immune responses.
DC migration relies on the dynamic remodeling of the actin cytoskeleton in response to
extracellular cues, for which ARP2/3 is a crucial factor. We have previously demonstrated that
Gadkin functions as an ARP2/3 inhibitor and that loss of Gadkin facilitates ARP2/3-dependent
cell spreading and cell migration in melanoma cells. Here, we addressed whether Gadkin defi-
ciency also alters migration of DCs. Our data show that loss of Gadkin significantly increases
F-actin levels and moderately, but likewise significantly impairs BMDC migration in vitro.
These findings are in contrast to our initial hypothesis, derived from experiments with B16F1
melanoma cells, that migration might be facilitated in the absence of Gadkin. However, actin
Fig 9. Loss of Gadkin impairs directed BMDCmigration towards CCL21 gradients in 3D collagen gels.
A-D. WT and Gadkin-/- BMDCs matured in the presence of LPS for 24 h were embedded into 1.6 mg/ml
collagen gels. The upper gel surface was covered with medium containing 650 ng/ml CCL19 or 650 ng/ml
CCL21, respectively. BMDC chemotaxis was monitored by bright-field real-time microscopy for 6 h. Images
were obtained at 4 min intervals. Velocity of migrating cells (A) was quantified as well as the accumulated (B)
and Euclidian distance (C) covered by the BMDCs. Directionality (D) was calculated as Euclidian distance
divided by accumulated distance (N = 5 independent experiments, at least 20 cells were tracked per
experiment, paired two-tailed t-test for comparison of WT and Gadkin-/- BMDCs subjected to same condition,
*** = p<0.001; ** = p<0.01).
doi:10.1371/journal.pone.0143883.g009
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Fig 10. Unaltered in vivo DCmigration in absence of Gadkin. A,B. Skin irritant-induced DCmigration to lymph nodes is not altered in the absence of
Gadkin. FITC in acetone/dibutylphtalate was painted onto the shaved skin of WT and Gadkin-/- mice. The percentage of FITC-positive DCs migrating to the
draining inguinal lymph nodes was assessed by flow cytometry. A. Representative examples of gating to select FITC-positive DCs for analysis (top). Lower
panels show control lymph nodes devoid of FITC-labeled DCs. B. Quantification of the percentage of FITC-positive cells in draining lymph nodes (N = 5 mice
per genotype from 2 independent experiments). C,D. Labeled LPS-matured WT and Gadkin-/- BMDCs reach the draining popliteal lymph nodes with
comparable efficiency after injection into foot pads. C. Representative example of gating to select transferred TAMRA- resp. DDAO-positive BMDCs for
analysis. D. Quantification of the percentage of TAMRA- and DDAO-positive WT and Gadkin-/- BMDCs in popliteal lymph nodes (LN) (N = 3 mice per
genotype from 2 independent experiments).
doi:10.1371/journal.pone.0143883.g010
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polymerization is controlled by a plethora of regulatory factors, and the cell-type specific com-
position of the actin regulatory proteome might modulate the precise effect of a single regula-
tory protein on cell migration. The fact that loss of Gadkin affects 2D migration also in the
absence of chemokines is consistent with a direct effect of Gadkin on actin dynamics by ARP2/
3 inhibition.
However, in 3D collagen gels Gadkin-/- BMDCs were only significantly slower in response
to a CCL21 gradient. This suggests that Gadkin does not affect actin-based cell motility in the
3D migration mode, but rather modulates chemotactic sensing. However, Ca2+ levels did not
appear to be different between LPS-matured WT and Gadkin-/- BMDCs following chemokine
application (signal intensity in KO as % of WT upon CCL19: 92.9 ± 7.0 (N = 6); upon CCL21:
108.9 ± 8.1 (N = 5)). Due to its role in recycling endosomal membrane traffic Gadkin might
putatively affect the composition of the DC surface proteome [17] thereby modulating DC sen-
sitivity to chemotactic cues. However, as CCL19 and CCL21 are both ligands for the same che-
motactic receptor, CCR7, this scenario seems unlikely, especially as we did not observe any
difference in the surface level of CCR7 (Fig 2J). Whereas both chemokines bind CCR7 with
similar affinity [23], CCL19 and CCL21 elicit different outcomes upon receptor activation in
regards to CCR7 internalization [24], downstream signaling events [25, 26] and migratory
mode [27]. In fact, CCL21, but not CCL19 activates DC adhesion to ligands like ICAM-1 [27].
Because of its link to endosomal trafficking and actin dynamics Gadkin might be involved in
the regulation of the CCL21-dependent adhesion thereby affecting migration efficiency. Alter-
natively, Gadkin could modulate CCL21-mediated intracellular CCR7 trafficking and signaling
responses, hypotheses which await further testing.
In contrast to our in vitro results in vivo DCmigration appeared not to be affected by the
loss of Gadkin limiting the physiological significance of the observed in vitro defects. This high-
lights the importance of in vivo experiments to test the physiological relevance of in vitro data
and, secondly, it suggests a high plasticity of the migration process as well as potential compen-
satory changes in the constitutive Gadkin KO animals that allow overall DC migration to still
work in the face of minor mechanistic defects. This is in line with previous observations on the
robustness of leukocyte migration. Even upon complete abrogation of adhesion and contrac-
tion or severe interference with actin dynamics, leukocytes were reported to still be able to
move [8, 22]. Depending on the chemokine being present and on the way it is presented within
the tissue (i.e. soluble vs. surface-bound) DCs can switch between distinct migratory modes
that involve different degrees of surface adhesion [23]. This ability to alternate between differ-
ent migration modes might well mask effects of Gadkin that are specific for one of the migra-
tion modes, especially as DCs encounter in vivo a mixture of differently presented chemokines,
presumably causing a greater flexibility in their migration pattern than in our in vitro experi-
ments where only one chemokine was present at a time.
The notion that the plasticity of DC migration might obscure effects of Gadkin deficiency is
especially appealing, as different facts point to an involvement of Gadkin in DC physiology.
We have shown that Gadkin is not only expressed by BMDCs, but that its protein levels are
upregulated upon LPS-induced DC maturation suggesting a specific function for Gadkin in
mature DCs. In addition, we detected for the first time a post-translational modification of
Gadkin, which transiently occurs shortly after the induction of DC maturation by LPS. The
exposure of DCs to inflammatory stimuli like LPS was reported to first induce a brief interval
of immobility and enhanced endocytic antigen uptake, before DCs re-arrange their repertoire
of chemokine receptors and migrate to lymph nodes [1, 28]. The transient post-translational
modification of Gadkin coincides with the described acute events after LPS encounter, thus
suggesting a role for Gadkin in the early phase of DC maturation, potentially related to the
transient stalling of migration.
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Furthermore, Gadkin is a candidate modifier gene for colitis severity. The spontaneous
ulcerative colitis (TRUC) developing in a DC-dependent manner in T-bet/RAG2 double
knockout mice [29] is highly penetrant in BALB/c mice, but less severe in C57BL/6 mice [30].
The cytokine deficiency-induced colitis susceptibility-1 (cdcs1) locus, which encodes 21 genes
expressed in DCs, was shown to control colitis severity. Gadkin, displaying 3.6-fold higher
transcript levels, is one of the three cdcs1-encoded genes, which were shown to be upregulated
in the more susceptible mouse strain [30]. This suggests that low Gadkin levels might be bene-
ficial for colitis prevention and, in accordance with our results, strengthens the link between
Gadkin and immune system functions. However, additional studies are clearly needed to eluci-
date the role of Gadkin in immunity and to identify its potential function in DC physiology.
Materials and Methods
Secondary antibodies were either conjugated to horseradish peroxidase (HRP) for Western
blot detection (GE Healthcare) or to Alexa-fluorophores in case of immunofluorescence exper-
iments (Invitrogen).
Animals
The generation of Gadkin-/- mice is described in [16]. Animals were backcrossed onto a
C57BL/6J background and housed on a 12 h light/dark cycle with food and water available ad
libitum in a specific pathogen free (SPF) facility. All experiments in the present study were car-
ried out in strict accordance with the guidelines of the Landesamt für Gesundheit und Soziales
(LAGeSo) Berlin. The study was specifically approved by the ethics committee of the LAGeSo
Berlin under animal experimentation permit number G 0185/14, and all efforts were made to
minimize suffering. All treatments were performed under isoflurane anesthesia. Animals were
sacrificed by cervical dislocation.
Isolation of immune cell populations
Mouse spleens were dissected into small pieces, digested for 40 min in 10 mg/ml Collagenase D
(Roche) at 37°C and mechanically dissociated using cell strainers (BD). Cells were washed in
PBS, exposed to ice-cold red cell removal buffer (RCRB: 0.15 M NH4Cl, 0.1 mM EDTA in
H2O) for 2 min to deplete erythrocytes, and washed twice in PBS before antibody staining was
performed as described below. Splenic T and B lymphocytes were isolated from total spleno-
cytes by FACS using anti-CD3e and anti-B220 surface staining, respectively. Cell sorting was
performed on a BD FACS Aria III.
Quantification of splenic DC subsets
Mouse spleens were dissociated into cell suspensions and depleted of erythrocytes as described
above. Different DC subsets were quantified by flow cytometry after antibody staining against
CD11c (for all splenic DCs), CD8 (to distinguish CD8-positive conventional DCs from
CD8-negative ones) and B220 (to label plasmacytoid DCs). For the determination of absolute
cell numbers 1x105 microbeads (Life Technologies, F8887) were added to each sample before
performing the staining protocol described below. After staining, the number of beads and
cells within each sample was quantified by flow cytometry. Initial total numbers of a specific
cell population were calculated as: initial number of cells = (105 x number of cells measured) /
number of beads measured.
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Generation of bone marrow-derived dendritic cells (BMDCs)
Ca. 6–9 weeks-old mice were sacrificed by cervical dislocation. Abdomen and hind legs were
sterilized with 70% ethanol. Murine bone marrow was isolated from femur and tibiae of the
hind legs by flushing the bones with ice-cold, sterile PBS using a 25G needle. Red blood cells
were lysed in RCRB. The resulting cell suspension was applied to a 70 μm cell strainer and then
centrifuged for 5 min at 300 x g at room temperature. 4x106 cells were resuspended in 10 ml
BMDC medium (RPMI 1640 containing 300 mg/l L-glutamine (ThermoFisher #11875), sup-
plemented with 10% fetal bovine serum (life technologies #10270106), 55 μM β-mercaptoetha-
nol (ThermoFisher #21985–023), 50 U/ml penicillin, 50 U/ml streptamycin (life technologies
#15140) and 30 ng/ml recombinant mouse GM-CSF (affymetrix eBioscience #BMS325) and
seeded into a 10 cm dish. On day 3, 6 and 8 GM-CSF-containing RPMI was renewed. Differen-
tiated BMDCs were used for experiments on day 9.
Preparation of lysates and immunoblot-based analysis
BMDCs were collected from the plate and centrifuged at 300 x g for 5 min at room tempera-
ture. The cell pellet was washed twice with PBS before lysis in lysis buffer (20 mMHEPES pH
7.4, 100 mM KCl, 2 mMMgCl2, 1% Triton X-100, 2 mM PMSF, 0.6% protease inhibitor cock-
tail (Sigma)). Adherent cell types were washed briefly with PBS on the plate before scraping
into lysis buffer. After 5 min on ice lysates were centrifuged at 4°C for 5 min at 17000 x g. The
protein concentration of the supernatant was determined by Bradford assay. Tissue extracts
were obtained by tissue homogenization in homogenization buffer (320 mM sucrose, 4 mM
HEPES pH 7.4, 2 mM PMSF, 0.3% protease inhibitor cocktail (Sigma)) using a potter (15
strokes at 1000 rpm). After centrifugation with 1000 x g at 4°C for 10 min, the supernatant was
collected and again cleared by centrifugation for 5 min with 17000 x g at 4°C to yield the final
tissue extract. Prior to immunoblotting lysates were adjusted to 1x Laemmli sample buffer.
Samples were analyzed by SDS-PAGE and immunoblotting. Bound primary antibodies were
detected by incubation with secondary antibodies conjugated to HRP and a chemiluminescent
substrate. Signals were either detected on film or using an imaging system from Biorad for
quantitative purposes. Band intensities were quantified with ImageJ and were normalized to
Hsc70.
Flow cytometry-based assays
Flow cytometry was used to quantify protein surface levels as well as polymerized actin and
Ca2+ levels. For surface stainings, cells were blocked with 5% BSA in PBS for 20 min and subse-
quently washed with PBS. Antibodies were applied for 30 min at 4°C in FACS buffer (2% FCS,
10 mM EDTA in PBS in case of CD11c and CD40 stainings; 0.1% BSA, 0.05% NaN3 in PBS for
all other stainings). For the detection of polymerized actin by intracellular phalloidin staining,
BMDCs were starved for 1 h in serum-free BMDCmedium before fixation with 4% parafor-
maldehyde. Fixed cells were permeabilized with 0.05% Triton X-100, 2% BSA in PBS for 30
min and stained with phalloidin-AF488 (1:50) for 1 h. After antibody staining all cells were
washed twice with PBS before resuspension in FACS buffer. Samples were immediately ana-
lyzed with a FACSCalibur or FACSCanto (BD Biosciences) using CellQuest Pro and FACS-
Diva, respectively. Analysis of Ca2+ levels following cytokine application was performed by
adjusting BMDCs to 1x106 cells/ml and equilibrating them to Ca2+ flux buffer (145 mMNaCl,
5 mM KCl, 1 mMMgCl, 1 mM CaCl, 1 mM Na2HPO4, 5 mM Glucose, 10 mMHEPES pH 7.5)
containing 4 μM Fluo-4 (life technologies) for 40 min at 37°C. Cells were washed once with
flux buffer and resuspended in 500 μl flux buffer. Baseline fluorescence in the FITC channel
was recorded for 60 s on a FACSCanto (BD). CCL19 or CCL21 were added (250 ng/ml), and
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FITC-fluorescence was again recorded for 120 s. Finally, 5 μM ionomycine were added to
mobilize the entire Ca2+ pool, and FITC-fluorescence was measured for another 60 s. Data
were analyzed with FlowJo V10.
FITC-dextran uptake
BMDCs were carefully detached with a cell scraper and resuspended at 5x105 cells per tube in
full BMDC medium. Cells were stimulated for 30 min with 100 ng/ml LPS at 37°C and then
incubated with 1 mg/ml FITC-dextran (life technologies) at 37°C for different durations. Dex-
tran uptake was stopped by washing cells twice with ice-cold RPMI. Control samples were
incubated with 1 mg/ml FITC-dextran, but kept on ice during the time course to determine
FITC-dextran background surface binding levels. Stopped samples were kept in 2% goat serum
in PBS on ice and rapidly analyzed by flow cytometry.
Immunofluorescence
Mature or immature BMDCs were harvested and seeded onto 50 μg/ml fibronectin-coated cov-
erslips. For immunofluorescence stainings cells were fixed with 4% PFA in PBS for 10 min at
room temperature. Cells were permeabilized and blocked with 0.5% Triton X-100 and 10%
goat serum in PBS (GSDB) for 5 min. Afterwards, samples were incubated with different pri-
mary antibodies in GSDB for 30 min at room temperature. After three short PBS washes, cov-
erslips were incubated with species-specific Alexa488- or Alexa568-labeled secondary
antibodies (Invitrogen) at a 1:200 dilution in GSDB for 1 h in the dark at room temperature.
To visualize F-actin, Alexa568-coupled phalloidin (Invitrogen) was applied at a 1:50 dilution in
GSDB together with the secondary antibodies. After the incubation, coverslips were washed
three times with PBS and mounted onto microscopy slides with ImmuMount mounting solu-
tion (Thermo Electron) supplemented with 1 μg/ml DAPI to stain nuclei. Images were taken
by spinning disc confocal microscopy using a Zeiss Axiovert 200M microscope (Carl Zeiss,
Jena, Germany) operated by Volocity, equipped with an EM-CCD-camera and a View ERS
Rapid Confocal Imager (Perkin Elmer, London, England). Image analysis was performed with
Fiji, an ImageJ 1.47g package.
2D DC chemotaxis assay
BMDCs were stimulated with 200 ng/ml LPS for 24 h. Mature BMDCs were harvested and left
to spread for at least 30 min in a chemotaxis chamber (μ-slice 3D chemotaxis chamber, Ibidi).
A gradient of 650 ng/ml CCL19 was applied as described in the user manual. Time-lapse mov-
ies of migrating cells were acquired with a 10x objective on a Nikon Eclipse Ti epifluorescent
microscope, equipped with an Andor sCMOS camera, an Okolab incubator for life cell imaging
(set to 37°C and 5% CO2) and a Nikon PerfectFocus autofocus system. The set-up was operated
by Micromanager 1.4.14. Images were acquired for 4 h at 2 min intervals. Cells were tracked
manually and analyzed with the free Chemotaxis and Migration Tool from Ibidi (Munich, Ger-
many) using ImageJ. Accumulated distance along the track and Euclidian distance were mea-
sured in μm, velocity was calculated as the accumulated distance divided by the time, and
directionality was calculated as the ratio of Euclidian distance to accumulated distance.
Transwell migration assay
1x105 mature BMDCs (stimulated with 200 ng/ml LPS for 24 h) were seeded into a Transwell
(Corning) with a pore size of 5 μm. BMDCs were allowed to migrate towards chemokine-free
RPMI, or towards 250 ng/ml CCL19 or 250 ng/ml CCL21 in RPMI for 3 h at 37°C as described
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in [31]. Migrated BMDCs were harvested from the lower chamber of the Transwell and
counted by flow cytometry for 60 s. 1x105 cells in suspension were used as 100% control.
Migration towards RPMI was defined as unspecific and was subtracted from the total migra-
tion towards chemokine to obtain the specific migration towards chemokine.
3D chemotaxis assay
Mature BMDCs were harvested and embedded into a 1.6 mg/ml collagen solution (PureCol,
bovine collagen solution type I, Advanced Biomatrix), which was cast into a home-made cham-
ber as described before [32]. After polymerization, the gel was covered with RPMI with or with-
out 650 ng/ml CCL19 or CCL21 and sealed with a paraffin/wax mixture. Cells were allowed to
migrate for 6 h at 37°C and 5% CO2. Images were taken every 4 min using the microscope sys-
tem described for the 2D DC chemotaxis assay. At least 20 cells were manually tracked and
analyzed per condition and experiment.
FITC painting assay
200 μl of fluorescein isothiocyanate (FITC; 5 mg/ml in 1:1 dibutylphtalate/acetone) was applied
onto the shaved abdomen of adult WT and Gadkin-/- mice anesthetized by isoflurane. On the
following day mice were sacrificed to isolate the draining inguinal lymph nodes. Lymph nodes
(LNs) were suspended into single cells by first mashing them with the end of a syringe in a
Petri dish and then applying the suspension to a 70 μm cell strainer. The suspension was centri-
fuged at 4°C for 5 min at 300 g. Cell pellets were resuspended in 200 μl FACS buffer and imme-
diately measured on a FACSCantoII flow cytometer (Becton Dickinson) using the BD
FACSDiva software. Data were quantified with FlowJo.
DC homing assay
LPS-matured WT and Gadkin-/- BMDCs were labeled with 10 μMTAMRA or 5 μMDDAO in
suspension for 10 min at room temperature, washed once with medium and quenched for 30
min in medium. Prior to injection cells were washed twice with PBS. 20 μl of a 1:1 mixture of
106 WT and Gadkin-/- BMDCs labeled with different dyes were injected intracutaneously (i.c.)
into a hind footpad of WT mice anaesthetized by isoflurane. Two days post-injection mice
were sacrificed to isolate popliteal lymph nodes. Lymph nodes were suspended into single cells
as described above, and cell composition was analyzed by flow cytometry as described above.
Statistical analyses
Values are depicted as mean ± SEM (standard error of the mean). Statistical significance of
data was analyzed by the indicated statistical tests using GraphPad Prism software, and are
indicated in the following way:  = p<0.0001;  = p<0.001;  = p<0.01;  = p<0.05. Data
with arbitrary absolute values, like fluorescent intensities, which for technical reasons showed
high variability between experiments, was normalized to the mean of all samples before per-
forming statistics. The number of experimental replica or animals used is given as “N”.
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